Breaking News

Hermes Pharma Announces Spin-out from Hermes Arzneimittel

CDMO specializes in the development and manufacture of user-friendly oral dosage forms for healthcare companies around the world.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

HERMES PHARMA, previously a division of HERMES Arzneimittel GmbH, has formed a separate legal entity named HERMES PHARMA GmbH and both will operate independently but remain part of the Johannes Burges Family Foundation. The move marks a new phase for HERMES PHARMA bringing greater independence while retaining long-term stability for the company’s third-party business.   HERMES PHARMA, a CDMO, specializes in the development and manufacture of user-friendly oral dosage forms for healthcare compani...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters